pfizer glp 1 Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race Readout Newsletter: Abeona, Pfizer, Regeneron,
Description
For example, triple-target agonists like retatrutide are leading multi-target GLP-1 drugs
What Is Retatrutide and Why Does the Mechanistic Profile Matter to Researchers
Sakaue S: OR = 0.78, 95% CI [0.760.80]
Its effects on inflammatory markers appear similar to other agents in the class, though with potentially less weight loss benefit than newer agents like semaglutide
